BioSpace News Archive

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, November 9, 2020, to provide a corporate update and discuss the Company’s financial results for the third quarter en

Biophytis SA announces that the first patient in Brazil has been dosed at Hospital e Maternidade Celso Pierro - PUCCAMP in Campinas in COVA, a Phase 2/3 Clinical Trial with Sarconeos for the treatment of patients with COVID-19-related respiratory failure.

Organs-on-chips or organ-on-a-chip is an electronic gadget that consists of a 3D microfluidic cell culture-based multi-channel structure.

Computer-assisted surgery or robotically assisted surgery or robotic surgery are the terms that are being used for the technological development that employs a robotic systems to assist in various surgical procedures.

RhoVac AB announces that the publication of the article on RhoVac’s Phase I/II study is set to be published in November.

International medical imaging IT and cybersecurity company Sectra is adding support for two additional file formats within digital pathology, and is now supporting all high-volume scanners for routine diagnostics.

Rapid Reshore & Development and BrainStorm Cell Therapeutics, Inc announced that BrainStorm has selected RR&D as its partner to expedite site selection and design services for a state-of-the-art manufacturing facility for NurOwn® in the U.S.

Anpac Bio-Medical Science Co., Ltd. announced that it has completed over 200,000 cancer detection tests as of September 30, 2020 using its biophysics based cancer screening technology, Cancer Differentiation Analysis.

BioXcel Therapeutics, Inc. announced that its Investigational New Drug application for BXCL501, the Company’s novel, proprietary, orally dissolving, sublingual thin film formulation of dexmedetomidine, has received clearance by the Division of Psychiatry Products at the U.S.

Trial evaluating the preliminary safety and efficacy of ATYR1923 vs placebo has exceeded enrollment.